| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $60.9M | +10.2% |
| R&D Expense | $57.2M | +104.9% |
| SG&A Expense | $17.1M | +152.3% |
| Operating Income | -$13.4M | -165.2% |
| Interest Expense | $294K | -37.2% |
| Pre-tax Income | -$17.1M | -185.2% |
| Net Income | -$17.1M | -185.2% |
| EPS (Basic) | -$0.63 | -179.7% |
| EPS (Diluted) | -$0.63 |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $33.2M | +163.3% |
| Accounts Receivable | $8.0M | -61.1% |
| Current Assets | $50.2M | — |
| Total Assets | $81.1M | — |
| Current Liabilities | $26.5M | +8539.8% |
| Total Liabilities | $42.6M | — |
| Stockholders' Equity | $38.5M | — |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.0M | -80.1% |
| Capital Expenditures | $10.9M | -14.0% |
| Investing Cash Flow | -$10.9M | +14.0% |
| Financing Cash Flow | $35.9M | +299.6% |
| Free Cash Flow | -$9.0M | -228.5% |
| -185.1% |